Efficacy and safety of single-agent pan-human epidermal growth factor receptor (HER) inhibitor dacomitinib in locally advanced unresectable or metastatic skin squamous cell cancer.
Sign Up to like & getrecommendations! Published in 2018 at "European journal of cancer"
DOI: 10.1016/j.ejca.2018.04.004
Abstract: BACKGROUND In recurrent or metastatic (R/M) skin squamous cell cancer (sSCC) not amenable to radiotherapy (RT) or surgery, chemotherapy (CT) has a palliative intent and limited clinical responses. The role of oral pan-HER inhibitor dacomitinib… read more here.
Keywords: skin squamous; squamous cell; skin; dacomitinib ... See more keywords
Tri-Site Academic Center Experience with Immunotherapy for Metastatic Skin Cancer in Solid Organ Transplant Patients
Sign Up to like & getrecommendations! Published in 2023 at "Southern Medical Journal"
DOI: 10.14423/smj.0000000000001508
Abstract: In this retrospective cohort study, the authors identified organ transplant recipients who developed metastatic skin cancer that was treated with an immune checkpoint inhibitor (ICI). ICIs have been successfully used to treat metastatic skin cancer… read more here.
Keywords: skin cancer; organ transplant; cancer; metastatic skin ... See more keywords